TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs4976646
log Bayes Factor = 4.93307
Chromosome 5   position 176,788,570  (GRCh37) Explore rs4976646 on Ensembl!
Variant rs4976646 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
N20.0 Calculus of kidney
1.000 0.000 0.000
N20 Calculus of kidney and ureter
0.995 0.005 0.000
N20.1 Calculus of ureter
0.993 0.007 0.000
N20.9 Urinary calculus, unspecified
0.921 0.079 0.000
N20.2 Calculus of kidney with calculus of ureter
0.470 0.530 0.000
N20-N23 Urolithiasis
0.375 0.625 0.000
N22 Calculus of urinary tract in diseases classified elsewhere
0.269 0.731 0.000
N21 Calculus of lower urinary tract
0.260 0.740 0.000
N23 Unspecified renal colic
0.257 0.743 0.000
M79.09 Rheumatism, unspecified (Site unspecified)
0.000 0.770 0.230
M79.0 Rheumatism, unspecified
0.000 0.780 0.220
M79.00 Rheumatism, unspecified (Multiple sites)
0.000 0.782 0.218
N21.8 Other lower urinary tract calculus
0.195 0.805 0.000
N22.8 Calculus of urinary tract in other diseases classified elsewhere
0.193 0.807 0.000
N22.0 Calculus of urinary tract in schistosomiasis [bilharziasis]
0.193 0.807 0.000
N21.9 Calculus of lower urinary tract, unspecified
0.186 0.814 0.000
N21.0 Calculus in bladder
0.186 0.814 0.000
M79.08 Rheumatism, unspecified (Other)
0.000 0.819 0.181
N21.1 Calculus in urethra
0.168 0.832 0.000
M79.06 Rheumatism, unspecified (Lower leg)
0.000 0.840 0.160
M79.07 Rheumatism, unspecified (Ankle and foot)
0.000 0.842 0.158
M79.05 Rheumatism, unspecified (Pelvic region and thigh)
0.000 0.842 0.158
M79.04 Rheumatism, unspecified (Hand)
0.000 0.842 0.158
M79.03 Rheumatism, unspecified (Forearm)
0.000 0.842 0.158
M79.02 Rheumatism, unspecified (Upper arm)
0.000 0.842 0.158
M79.01 Rheumatism, unspecified (Shoulder region)
0.000 0.846 0.154
T85.5 Mechanical complication of gastro-intestinal prosthetic devices, implants and grafts
0.000 0.976 0.024
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.024 0.976 0.000
T39.1 4-Aminophenol derivatives
0.024 0.976 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.023 0.977 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.022 0.978 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.022 0.978 0.000
N00-N08 Glomerular diseases
0.021 0.979 0.000
H73.8 Other specified disorders of tympanic membrane
0.000 0.979 0.021
N04 Nephrotic syndrome
0.021 0.979 0.000
N04.9 Unspecified
0.021 0.979 0.000
C90.0 Multiple myeloma
0.021 0.979 0.000
N03 Chronic nephritic syndrome
0.020 0.980 0.000
N05 Unspecified nephritic syndrome
0.020 0.980 0.000
T43.6 Psychostimulants with abuse potential
0.020 0.980 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.019 0.981 0.000
N05.9 Unspecified
0.019 0.981 0.000
N03.9 Unspecified
0.019 0.981 0.000
N05.8 Other
0.019 0.981 0.000
T39.0 Salicylates
0.019 0.981 0.000
T43.9 Psychotropic drug, unspecified
0.019 0.981 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.019 0.981 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.019 0.981 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.018 0.982 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.018 0.982 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.018 0.982 0.000
N02 Recurrent and persistent haematuria
0.018 0.982 0.000
N04.0 Minor glomerular abnormality
0.017 0.983 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.017 0.983 0.000
T39.4 Antirheumatics, not elsewhere classified
0.017 0.983 0.000
T39.2 Pyrazolone derivatives
0.017 0.983 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.016 0.984 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.016 0.984 0.000
N03.8 Other
0.016 0.984 0.000
N03.1 Focal and segmental glomerular lesions
0.016 0.984 0.000
N03.5 Diffuse mesangiocapillary glomerulonephritis
0.016 0.984 0.000
N02.9 Unspecified
0.016 0.984 0.000
N00 Acute nephritic syndrome
0.015 0.984 0.000
N07 Hereditary nephropathy, not elsewhere classified
0.015 0.984 0.000
N06 Isolated proteinuria with specified morphological lesion
0.015 0.984 0.000
N01 Rapidly progressive nephritic syndrome
0.015 0.984 0.000
N04.8 Other
0.015 0.985 0.000
N04.7 Diffuse crescentic glomerulonephritis
0.015 0.985 0.000
N04.6 Dense deposit disease
0.015 0.985 0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis
0.015 0.985 0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis
0.015 0.985 0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis
0.015 0.985 0.000
H53.8 Other visual disturbances
0.015 0.985 0.000
N05.5 Diffuse mesangiocapillary glomerulonephritis
0.015 0.985 0.000
N04.1 Focal and segmental glomerular lesions
0.015 0.985 0.000
N04.2 Diffuse membranous glomerulonephritis
0.015 0.985 0.000
H53.9 Visual disturbance, unspecified
0.015 0.985 0.000
N03.7 Diffuse crescentic glomerulonephritis
0.015 0.985 0.000
N03.6 Dense deposit disease
0.015 0.985 0.000
N03.4 Diffuse endocapillary proliferative glomerulonephritis
0.015 0.985 0.000
N03.3 Diffuse mesangial proliferative glomerulonephritis
0.015 0.985 0.000
N03.2 Diffuse membranous glomerulonephritis
0.015 0.985 0.000
N03.0 Minor glomerular abnormality
0.015 0.985 0.000
N05.6 Dense deposit disease
0.015 0.985 0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis
0.015 0.985 0.000
N05.0 Minor glomerular abnormality
0.015 0.985 0.000
N08 Glomerular disorders in diseases classified elsewhere
0.015 0.985 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.015 0.985 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.015 0.985 0.000
M79.7 Fibromyalgia
0.000 0.985 0.015
D32.0 Cerebral meninges
0.014 0.986 0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis
0.014 0.986 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.014 0.986 0.000
M79 Other soft tissue disorders, not elsewhere classified
0.000 0.986 0.014
N05.1 Focal and segmental glomerular lesions
0.014 0.986 0.000
M79.79 Fibromyalgia (Site unspecified)
0.000 0.986 0.014
N02.1 Focal and segmental glomerular lesions
0.014 0.986 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.014 0.986 0.000
N05.2 Diffuse membranous glomerulonephritis
0.014 0.986 0.000
T47.0 Histamine H(2)-receptor antagonists
0.014 0.986 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.014 0.986 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.014 0.986 0.000
T47.4 Other laxatives
0.013 0.986 0.000
T47.2 Stimulant laxatives
0.013 0.986 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.013 0.987 0.000
M79.70 Fibromyalgia (Multiple sites)
0.000 0.987 0.013
N02.7 Diffuse crescentic glomerulonephritis
0.013 0.987 0.000
N02.6 Dense deposit disease
0.013 0.987 0.000
N02.5 Diffuse mesangiocapillary glomerulonephritis
0.013 0.987 0.000
N02.4 Diffuse endocapillary proliferative glomerulonephritis
0.013 0.987 0.000
N02.3 Diffuse mesangial proliferative glomerulonephritis
0.013 0.987 0.000
N02.0 Minor glomerular abnormality
0.013 0.987 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.013 0.987 0.000
H53 Visual disturbances
0.013 0.987 0.000
T36 Poisoning by systemic antibiotics
0.013 0.987 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.012 0.987 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.012 0.987 0.000
T47.7 Emetics
0.012 0.987 0.000
T47.6 Antidiarrhoeal drugs
0.012 0.987 0.000
T47.5 Digestants
0.012 0.987 0.000
T47.3 Saline and osmotic laxatives
0.012 0.987 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.012 0.988 0.000
H73 Other disorders of tympanic membrane
0.000 0.988 0.012
N05.7 Diffuse crescentic glomerulonephritis
0.012 0.988 0.000
N02.2 Diffuse membranous glomerulonephritis
0.012 0.988 0.000
N02.8 Other
0.012 0.988 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.012 0.988 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.011 0.988 0.000
M79.5 Residual foreign body in soft tissue
0.000 0.988 0.012
N00.9 Unspecified
0.011 0.988 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.011 0.988 0.000
N00.8 Other
0.011 0.989 0.000
N00.7 Diffuse crescentic glomerulonephritis
0.011 0.989 0.000
N00.6 Dense deposit disease
0.011 0.989 0.000
N00.5 Diffuse mesangiocapillary glomerulonephritis
0.011 0.989 0.000
N00.4 Diffuse endocapillary proliferative glomerulonephritis
0.011 0.989 0.000
N00.3 Diffuse mesangial proliferative glomerulonephritis
0.011 0.989 0.000
N00.2 Diffuse membranous glomerulonephritis
0.011 0.989 0.000
N00.1 Focal and segmental glomerular lesions
0.011 0.989 0.000
N00.0 Minor glomerular abnormality
0.011 0.989 0.000
N01.9 Unspecified
0.011 0.989 0.000
N01.8 Other
0.011 0.989 0.000
N01.7 Diffuse crescentic glomerulonephritis
0.011 0.989 0.000
N01.6 Dense deposit disease
0.011 0.989 0.000
N01.5 Diffuse mesangiocapillary glomerulonephritis
0.011 0.989 0.000
N01.4 Diffuse endocapillary proliferative glomerulonephritis
0.011 0.989 0.000
N01.3 Diffuse mesangial proliferative glomerulonephritis
0.011 0.989 0.000
N01.2 Diffuse membranous glomerulonephritis
0.011 0.989 0.000
N01.1 Focal and segmental glomerular lesions
0.011 0.989 0.000
N01.0 Minor glomerular abnormality
0.011 0.989 0.000
N06.9 Unspecified
0.011 0.989 0.000
N06.8 Other
0.011 0.989 0.000
N06.7 Diffuse crescentic glomerulonephritis
0.011 0.989 0.000
N06.6 Dense deposit disease
0.011 0.989 0.000
N06.5 Diffuse mesangiocapillary glomerulonephritis
0.011 0.989 0.000
N06.4 Diffuse endocapillary proliferative glomerulonephritis
0.011 0.989 0.000
N06.3 Diffuse mesangial proliferative glomerulonephritis
0.011 0.989 0.000
N06.2 Diffuse membranous glomerulonephritis
0.011 0.989 0.000
N06.1 Focal and segmental glomerular lesions
0.011 0.989 0.000
N06.0 Minor glomerular abnormality
0.011 0.989 0.000
N07.9 Unspecified
0.011 0.989 0.000
N07.8 Other
0.011 0.989 0.000
N07.7 Diffuse crescentic glomerulonephritis
0.011 0.989 0.000
N07.6 Dense deposit disease
0.011 0.989 0.000
N07.5 Diffuse mesangiocapillary glomerulonephritis
0.011 0.989 0.000
N07.4 Diffuse endocapillary proliferative glomerulonephritis
0.011 0.989 0.000
N07.3 Diffuse mesangial proliferative glomerulonephritis
0.011 0.989 0.000
N07.2 Diffuse membranous glomerulonephritis
0.011 0.989 0.000
N07.1 Focal and segmental glomerular lesions
0.011 0.989 0.000
N07.0 Minor glomerular abnormality
0.011 0.989 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.011 0.989 0.000
N08.3 Glomerular disorders in diabetes mellitus
0.011 0.989 0.000
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases
0.011 0.989 0.000
C90.2 Plasmacytoma, extramedullary
0.011 0.989 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.011 0.989 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.011 0.989 0.000
T38.1 Thyroid hormones and substitutes
0.011 0.989 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.011 0.989 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.011 0.989 0.000
H53.0 Amblyopia ex anopsia
0.011 0.989 0.000
N08.8 Glomerular disorders in other diseases classified elsewhere
0.011 0.989 0.000
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism
0.011 0.989 0.000
N08.1 Glomerular disorders in neoplastic diseases
0.011 0.989 0.000
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere
0.011 0.989 0.000
F17.2 Dependence syndrome
0.000 0.989 0.011
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.011 0.989 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.011 0.989 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.011 0.989 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.011 0.989 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.011 0.989 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.011 0.989 0.000
T44.0 Anticholinesterase agents
0.011 0.989 0.000
M79.78 Fibromyalgia (Other)
0.000 0.989 0.011
M79.77 Fibromyalgia (Ankle and foot)
0.000 0.989 0.011
M79.76 Fibromyalgia (Lower leg)
0.000 0.989 0.011
M79.75 Fibromyalgia (Pelvic region and thigh)
0.000 0.989 0.011
M79.74 Fibromyalgia (Hand)
0.000 0.989 0.011
M79.73 Fibromyalgia (Forearm)
0.000 0.989 0.011
M79.72 Fibromyalgia (Upper arm)
0.000 0.989 0.011
M79.71 Fibromyalgia (Shoulder region)
0.000 0.989 0.011
C90.3 Solitary plasmacytoma
0.011 0.989 0.000
N99.4 Postprocedural pelvic peritoneal adhesions
0.011 0.989 0.000
T48.5 Anti-common-cold drugs
0.010 0.989 0.000
M79.3 Panniculitis, unspecified
0.000 0.990 0.010
T38.9 Other and unspecified hormone antagonists
0.010 0.990 0.000
T38.7 Androgens and anabolic congeners
0.010 0.990 0.000
T38.5 Other oestrogens and progestogens
0.010 0.990 0.000
T38.4 Oral contraceptives
0.010 0.990 0.000
T38.2 Antithyroid drugs
0.010 0.990 0.000
T38.0 Glucocorticoids and synthetic analogues
0.010 0.990 0.000
H71 Cholesteatoma of middle ear
0.000 0.990 0.010
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.010 0.990 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.010 0.990 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.010 0.990 0.000
T48.4 Expectorants
0.010 0.990 0.000
T48.3 Antitussives
0.010 0.990 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.010 0.990 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.010 0.990 0.000
T48.0 Oxytocic drugs
0.010 0.990 0.000
T41.5 Therapeutic gases
0.010 0.990 0.000
T41.4 Anaesthetic, unspecified
0.010 0.990 0.000
T41.3 Local anaesthetics
0.010 0.990 0.000
T41.2 Other and unspecified general anaesthetics
0.010 0.990 0.000
T41.1 Intravenous anaesthetics
0.010 0.990 0.000
T41.0 Inhaled anaesthetics
0.010 0.990 0.000
T49.9 Topical agent, unspecified
0.010 0.990 0.000
T49.8 Other topical agents
0.010 0.990 0.000
T49.7 Dental drugs, topically applied
0.010 0.990 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.010 0.990 0.000
T49.5 Ophthalmological drugs and preparations
0.010 0.990 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.010 0.990 0.000
T49.3 Emollients, demulcents and protectants
0.010 0.990 0.000
T49.2 Local astringents and local detergents
0.010 0.990 0.000
T49.1 Antipruritics
0.010 0.990 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.010 0.990 0.000
M79.9 Soft tissue disorder, unspecified
0.000 0.990 0.010
M79.54 Residual foreign body in soft tissue (Hand)
0.000 0.990 0.010
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.010 0.990 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.010 0.990 0.000
T46.7 Peripheral vasodilators
0.010 0.990 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.010 0.990 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.010 0.990 0.000
M79.4 Hypertrophy of (infrapatellar) fat pad
0.000 0.990 0.009
N08.5 Glomerular disorders in systemic connective tissue disorders
0.009 0.990 0.000
T45.2 Vitamins, not elsewhere classified
0.009 0.991 0.000
H53.6 Night blindness
0.009 0.991 0.000
H53.5 Colour vision deficiencies
0.009 0.991 0.000
H53.3 Other disorders of binocular vision
0.009 0.991 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.009 0.991 0.000
T36.9 Systemic antibiotic, unspecified
0.009 0.991 0.000
T36.8 Other systemic antibiotics
0.009 0.991 0.000
T36.7 Antifungal antibiotics, systemically used
0.009 0.991 0.000
T36.6 Rifamycins
0.009 0.991 0.000
T36.5 Aminoglycosides
0.009 0.991 0.000
T36.4 Tetracyclines
0.009 0.991 0.000
T36.3 Macrolides
0.009 0.991 0.000
T36.2 Chloramphenicol group
0.009 0.991 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.009 0.991 0.000
M79.96 Soft tissue disorder, unspecified (Lower leg)
0.000 0.991 0.009
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.009 0.991 0.000
T37.5 Antiviral drugs
0.009 0.991 0.000
T37.4 Anthelminthics
0.009 0.991 0.000
T37.3 Other antiprotozoal drugs
0.009 0.991 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.009 0.991 0.000
T37.1 Antimycobacterial drugs
0.009 0.991 0.000
T37.0 Sulphonamides
0.009 0.991 0.000
C90.1 Plasma cell leukaemia
0.009 0.991 0.000
H73.0 Acute myringitis
0.000 0.991 0.009
M79.58 Residual foreign body in soft tissue (Other)
0.000 0.991 0.009
M79.57 Residual foreign body in soft tissue (Ankle and foot)
0.000 0.991 0.009
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.009 0.991 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.008 0.991 0.000
T45.8 Other primarily systemic and haematological agents
0.008 0.991 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.008 0.991 0.000
T45.6 Fibrinolysis-affecting drugs
0.008 0.991 0.000
T45.4 Iron and its compounds
0.008 0.991 0.000
T45.3 Enzymes, not elsewhere classified
0.008 0.991 0.000
M79.59 Residual foreign body in soft tissue (Site unspecified)
0.000 0.991 0.008
M79.55 Residual foreign body in soft tissue (Pelvic region and thigh)
0.000 0.991 0.008
M79.53 Residual foreign body in soft tissue (Forearm)
0.000 0.991 0.008
M79.52 Residual foreign body in soft tissue (Upper arm)
0.000 0.991 0.008
M79.51 Residual foreign body in soft tissue (Shoulder region)
0.000 0.991 0.008
M79.50 Residual foreign body in soft tissue (Multiple sites)
0.000 0.991 0.008
W19.4 Street and highway
0.009 0.991 0.000
H53.4 Visual field defects
0.008 0.992 0.000
T36.0 Penicillins
0.008 0.992 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.008 0.992 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.008 0.992 0.000
H73.9 Disorder of tympanic membrane, unspecified
0.000 0.992 0.008
T45.0 Antiallergic and antiemetic drugs
0.008 0.992 0.000
H65-H75 Diseases of middle ear and mastoid
0.000 0.992 0.008
T50.8 Diagnostic agents
0.008 0.992 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.008 0.992 0.000
H73.1 Chronic myringitis
0.000 0.992 0.008
T37.8 Other specified systemic anti-infectives and antiparasitics
0.007 0.992 0.000
M79.39 Panniculitis, unspecified (Site unspecified)
0.000 0.992 0.008
M79.38 Panniculitis, unspecified (Other)
0.000 0.992 0.008
M79.37 Panniculitis, unspecified (Ankle and foot)
0.000 0.992 0.008
M79.36 Panniculitis, unspecified (Lower leg)
0.000 0.992 0.008
M79.35 Panniculitis, unspecified (Pelvic region and thigh)
0.000 0.992 0.008
M79.34 Panniculitis, unspecified (Hand)
0.000 0.992 0.008
M79.33 Panniculitis, unspecified (Forearm)
0.000 0.992 0.008
M79.32 Panniculitis, unspecified (Upper arm)
0.000 0.992 0.008
M79.31 Panniculitis, unspecified (Shoulder region)
0.000 0.992 0.008
M79.30 Panniculitis, unspecified (Multiple sites)
0.000 0.992 0.008
T50.7 Analeptics and opioid receptor antagonists
0.008 0.992 0.000
T50.5 Appetite depressants
0.008 0.992 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.008 0.992 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.008 0.992 0.000
T50.1 Loop [high-ceiling] diuretics
0.008 0.992 0.000
T50.0 Mineralocorticoids and their antagonists
0.008 0.992 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.007 0.992 0.000
M79.95 Soft tissue disorder, unspecified (Pelvic region and thigh)
0.000 0.992 0.007
M79.93 Soft tissue disorder, unspecified (Forearm)
0.000 0.992 0.007
M79.92 Soft tissue disorder, unspecified (Upper arm)
0.000 0.992 0.007
M79.91 Soft tissue disorder, unspecified (Shoulder region)
0.000 0.992 0.007
M79.90 Soft tissue disorder, unspecified (Multiple sites)
0.000 0.992 0.007
L05.0 Pilonidal cyst with abscess
0.000 0.993 0.007
M79.56 Residual foreign body in soft tissue (Lower leg)
0.000 0.993 0.007
M79.49 Hypertrophy of (infrapatellar) fat pad-Site unspec
0.000 0.993 0.007
M79.48 Hypertrophy of (infrapatellar) fat pad (Other)
0.000 0.993 0.007
M79.47 Hypertrophy of (infrapatellar) fat pad (Ankle and foot)
0.000 0.993 0.007
M79.45 Hypertrophy of (infrapatellar) fat pad (Pelvic region and thigh)
0.000 0.993 0.007
M79.44 Hypertrophy of (infrapatellar) fat pad (Hand)
0.000 0.993 0.007
M79.43 Hypertrophy of (infrapatellar) fat pad (Forearm)
0.000 0.993 0.007
M79.42 Hypertrophy of (infrapatellar) fat pad (Upper arm)
0.000 0.993 0.007
M79.41 Hypertrophy of (infrapatellar) fat pad (Shoulder region)
0.000 0.993 0.007
M79.40 Hypertrophy of (infrapatellar) fat pad (Multiple sites)
0.000 0.993 0.007
M79.97 Soft tissue disorder, unspecified (Ankle and foot)
0.000 0.993 0.007
S42.10 Fracture of scapula (closed)
0.007 0.993 0.000
H53.1 Subjective visual disturbances
0.007 0.993 0.000
H66.3 Other chronic suppurative otitis media
0.000 0.993 0.007
H66 Suppurative and unspecified otitis media
0.000 0.993 0.007
T50.4 Drugs affecting uric acid metabolism
0.006 0.993 0.000
M79.99 Soft tissue disorder, unspecified (Site unspecified)
0.000 0.993 0.006
L60.0 Ingrowing nail
0.000 0.993 0.007
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.006 0.993 0.000
T40.8 Lysergide [LSD]
0.006 0.993 0.000
T40.7 Cannabis (derivatives)
0.006 0.993 0.000
T40.5 Cocaine
0.006 0.993 0.000
T40.3 Methadone
0.006 0.993 0.000
T40.1 Heroin
0.006 0.993 0.000
T40.0 Opium
0.006 0.993 0.000
D32 Benign neoplasm of meninges
0.007 0.993 0.000
M79.94 Soft tissue disorder, unspecified (Hand)
0.000 0.993 0.006
H74 Other disorders of middle ear and mastoid
0.000 0.994 0.006
T40.4 Other synthetic narcotics
0.006 0.994 0.000
M79.46 Hypertrophy of (infrapatellar) fat pad (Lower leg)
0.000 0.994 0.006
T46.1 Calcium-channel blockers
0.006 0.994 0.000
H69 Other disorders of Eustachian tube
0.000 0.994 0.006
T45.5 Anticoagulants
0.006 0.994 0.000
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere
0.000 0.994 0.006
H68 Eustachian salpingitis and obstruction
0.000 0.994 0.006
H67 Otitis media in diseases classified elsewhere
0.000 0.994 0.006
H53-H54 Visual disturbances and blindness
0.006 0.994 0.000
M79.98 Soft tissue disorder, unspecified (Other)
0.000 0.994 0.006
D32.9 Meninges, unspecified
0.006 0.994 0.000
H74.3 Other acquired abnormalities of ear ossicles
0.000 0.994 0.006
I44.2 Atrioventricular block, complete
0.000 0.994 0.006
H74.4 Polyp of middle ear
0.000 0.994 0.006
H70 Mastoiditis and related conditions
0.000 0.994 0.006
H66.1 Chronic tubotympanic suppurative otitis media
0.000 0.994 0.006
Z09.8 Follow-up examination after other treatment for other conditions
0.000 0.994 0.006
T40.6 Other and unspecified narcotics
0.005 0.994 0.000
H74.2 Discontinuity and dislocation of ear ossicles
0.000 0.995 0.005
Chapter XIV Diseases of the genitourinary system
0.005 0.995 0.000
M79.1 Myalgia
0.000 0.995 0.005
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.005 0.995 0.000
H74.8 Other specified disorders of middle ear and mastoid
0.000 0.995 0.005
H54.7 Unspecified visual loss
0.005 0.995 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.005 0.995 0.000
H54 Blindness and low vision
0.005 0.995 0.000
H69.8 Other specified disorders of Eustachian tube
0.000 0.995 0.005
H69.0 Patulous Eustachian tube
0.000 0.995 0.005
Z91.1 Personal history of noncompliance with medical treatment and regimen
0.000 0.995 0.005
H67.8 Otitis media in other diseases classified elsewhere
0.000 0.995 0.004
H67.1 Otitis media in viral diseases classified elsewhere
0.000 0.995 0.004
H67.0 Otitis media in bacterial diseases classified elsewhere
0.000 0.995 0.004
H68.1 Obstruction of Eustachian tube
0.000 0.995 0.004
H68.0 Eustachian salpingitis
0.000 0.995 0.004
H75.8 Other specified disorders of middle ear and mastoid in diseases classified elsewhere
0.000 0.995 0.004
H75.0 Mastoiditis in infectious and parasitic diseases classified elsewhere
0.000 0.995 0.004
N99-N99 Other disorders of the genitourinary system
0.005 0.995 0.000
H66.4 Suppurative otitis media, unspecified
0.000 0.995 0.004
H69.9 Eustachian tube disorder, unspecified
0.000 0.995 0.005
L05 Pilonidal cyst
0.000 0.995 0.005
H66.2 Chronic atticoantral suppurative otitis media
0.000 0.995 0.004
H47.1 Papilloedema, unspecified
0.005 0.995 0.000
I71.2 Thoracic aortic aneurysm, without mention of rupture
0.004 0.995 0.000
H66.9 Otitis media, unspecified
0.000 0.996 0.004
H66.0 Acute suppurative otitis media
0.000 0.996 0.004
H70.8 Other mastoiditis and related conditions
0.000 0.996 0.004
H70.2 Petrositis
0.000 0.996 0.004
H70.1 Chronic mastoiditis
0.000 0.996 0.004
H70.0 Acute mastoiditis
0.000 0.996 0.004
N31.8 Other neuromuscular dysfunction of bladder
0.000 0.996 0.004
H54.1 Blindness, one eye, low vision, other eye
0.004 0.996 0.000
N99 Postprocedural disorders of genito-urinary system, not elsewhere classified
0.004 0.996 0.000
I82.9 Embolism and thrombosis of unspecified vein
0.004 0.996 0.000
H74.1 Adhesive middle ear disease
0.000 0.996 0.004
I82.8 Embolism and thrombosis of other specified veins
0.004 0.996 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.004 0.996 0.000
H54.9 Unspecified visual impairment (binocular)
0.004 0.996 0.000
M79.19 Myalgia (Site unspecified)
0.000 0.996 0.004
M79.16 Myalgia (Lower leg)
0.000 0.996 0.004
M79.17 Myalgia (Ankle and foot)
0.000 0.996 0.004
M79.14 Myalgia (Hand)
0.000 0.996 0.004
M79.13 Myalgia (Forearm)
0.000 0.996 0.004
M79.12 Myalgia (Upper arm)
0.000 0.996 0.004
T40.2 Other opioids
0.004 0.996 0.000
H54.0 Blindness, both eyes
0.004 0.996 0.000
M79.2 Neuralgia and neuritis, unspecified
0.000 0.996 0.004
T42.5 Mixed antiepileptics, not elsewhere classified
0.004 0.996 0.000
T42.3 Barbiturates
0.004 0.996 0.000
T42.2 Succinimides and oxazolidinediones
0.004 0.996 0.000
I71.4 Abdominal aortic aneurysm, without mention of rupture
0.004 0.996 0.000
F00.9 Dementia in Alzheimer's disease, unspecified
0.000 0.996 0.004
H70.9 Mastoiditis, unspecified
0.000 0.996 0.004
H54.3 Unqualified visual loss, both eyes
0.004 0.996 0.000
I71.9 Aortic aneurysm of unspecified site, without mention of rupture
0.004 0.996 0.000
T92.2 Sequelae of fracture at wrist and hand level
0.000 0.996 0.004
H74.9 Disorder of middle ear and mastoid, unspecified
0.000 0.996 0.004
L05.9 Pilonidal cyst without abscess
0.000 0.996 0.004
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.004 0.996 0.000
I71 Aortic aneurysm and dissection
0.004 0.996 0.000
K86.3 Pseudocyst of pancreas
0.000 0.996 0.004
D32.1 Spinal meninges
0.003 0.996 0.000
J06.9 Acute upper respiratory infection, unspecified
0.004 0.996 0.000
M79.11 Myalgia (Shoulder region)
0.000 0.996 0.003
M79.15 Myalgia (Pelvic region and thigh)
0.000 0.996 0.003
N81.4 Uterovaginal prolapse, unspecified
0.000 0.996 0.004
N99.0 Postprocedural renal failure
0.004 0.996 0.000
L08.8 Other specified local infections of skin and subcutaneous tissue
0.000 0.996 0.004
H54.6 Unqualified visual loss, one eye
0.003 0.996 0.000
I71.0 Dissection of aorta [any part]
0.003 0.997 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.003 0.997 0.000
I97.8 Other postprocedural disorders of circulatory system, not elsewhere classified
0.003 0.997 0.000
N99.1 Postprocedural urethral stricture
0.003 0.997 0.000
I82 Other venous embolism and thrombosis
0.003 0.997 0.000
M79.18 Myalgia (Other)
0.000 0.997 0.003
L60 Nail disorders
0.000 0.997 0.003
H54.2 Low vision, both eyes
0.003 0.997 0.000
M34.9 Systemic sclerosis, unspecified
0.003 0.997 0.000
T42.0 Hydantoin derivatives
0.003 0.997 0.000
L60.2 Onychogryphosis
0.000 0.997 0.003
S42.1 Fracture of scapula
0.003 0.997 0.000
M79.24 Neuralgia and neuritis, unspecified (Hand)
0.000 0.997 0.003
M79.23 Neuralgia and neuritis, unspecified (Forearm)
0.000 0.997 0.003
M79.22 Neuralgia and neuritis, unspecified (Upper arm)
0.000 0.997 0.003
M79.21 Neuralgia and neuritis, unspecified (Shoulder region)
0.000 0.997 0.003
T42.1 Iminostilbenes
0.003 0.997 0.000
M79.26 Neuralgia and neuritis, unspecified (Lower leg)
0.000 0.997 0.003
F00 Dementia in Alzheimer's disease
0.000 0.997 0.003
N99.5 Malfunction of external stoma of urinary tract
0.003 0.997 0.000
T85.6 Mechanical complication of other specified internal prosthetic devices, implants and grafts
0.000 0.997 0.003
H74.0 Tympanosclerosis
0.000 0.997 0.003
I71.8 Aortic aneurysm of unspecified site, ruptured
0.003 0.997 0.000
I71.5 Thoracoabdominal aortic aneurysm, ruptured
0.003 0.997 0.000
J01.9 Acute sinusitis, unspecified
0.003 0.997 0.000
F00.2 Dementia in Alzheimer's disease, atypical or mixed type
0.000 0.997 0.003
H54.5 Low vision, one eye
0.003 0.997 0.000
L60.3 Nail dystrophy
0.000 0.997 0.003
I71.1 Thoracic aortic aneurysm, ruptured
0.003 0.997 0.000
M79.27 Neuralgia and neuritis, unspecified (Ankle and foot)
0.000 0.997 0.003
M79.20 Neuralgia and neuritis, unspecified (Multiple sites)
0.000 0.997 0.003
I71.6 Thoracoabdominal aortic aneurysm, without mention of rupture
0.003 0.997 0.000
M70.22 Olecranon bursitis-Upper arm
0.000 0.997 0.003
K86.0 Alcohol-induced chronic pancreatitis
0.000 0.997 0.003
N99.9 Postprocedural disorder of genito-urinary system, unspecified
0.003 0.997 0.000
N25-N29 Other disorders of kidney and ureter
0.003 0.997 0.000
F00.0 Dementia in Alzheimer's disease with early onset
0.000 0.997 0.003
N26 Unspecified contracted kidney
0.003 0.997 0.000
I82.1 Thrombophlebitis migrans
0.003 0.997 0.000
T92.6 Sequelae of crushing injury and traumatic amputation of upper limb
0.000 0.997 0.003
L60.5 Yellow nail syndrome
0.000 0.997 0.003
L60.4 Beau's lines
0.000 0.997 0.003
L60.1 Onycholysis
0.000 0.997 0.003
J06 Acute upper respiratory infections of multiple and unspecified sites
0.003 0.997 0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.997 0.003
M19.17 Post-traumatic arthrosis of other joints (Ankle and foot)
0.003 0.997 0.000
I82.0 Budd-Chiari syndrome
0.002 0.997 0.000
J01 Acute sinusitis
0.003 0.997 0.000
T43.2 Other and unspecified antidepressants
0.003 0.997 0.000
M79.25 Neuralgia and neuritis, unspecified (Pelvic region and thigh)
0.000 0.997 0.002
J01.1 Acute frontal sinusitis
0.003 0.997 0.000
S42.11 Fracture of scapula (open)
0.002 0.997 0.000
E80.4 Gilbert's syndrome
0.003 0.997 0.000
K90.9 Intestinal malabsorption, unspecified
0.000 0.997 0.003
I20.8 Other forms of angina pectoris
0.000 0.997 0.003
T92 Sequelae of injuries of upper limb
0.000 0.997 0.003
I82.3 Embolism and thrombosis of renal vein
0.002 0.997 0.000
M34.8 Other forms of systemic sclerosis
0.002 0.997 0.000
F00.1 Dementia in Alzheimer's disease with late onset
0.000 0.998 0.002
I82.2 Embolism and thrombosis of vena cava
0.002 0.998 0.000
M34 Systemic sclerosis
0.002 0.998 0.000
F33.1 Recurrent depressive disorder, current episode moderate
0.002 0.998 0.000
H65 Nonsuppurative otitis media
0.000 0.998 0.002
T92.1 Sequelae of fracture of arm
0.000 0.998 0.002
H47 Other disorders of optic [2nd] nerve and visual pathways
0.002 0.998 0.000
M87.95 Osteonecrosis, unspecified (Pelvic region and thigh)
0.000 0.998 0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.